Williams David Solomon III Buys Shares of AdaptHealth Corp.
Williams David Solomon III purchased 18,999 shares of AdaptHealth Corp. on June 24, 2026.
Key Points
- Williams David Solomon III bought 18,999 shares of AdaptHealth Corp. (AHCO) on June 24, 2026.
- AdaptHealth has a market cap of about $1.4 billion and a forward P/E ratio of 8.75.
- RBC Capital maintained a 'buy' rating on AdaptHealth with a $15 target on May 11, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
AdaptHealth Corp. (NasdaqCM:AHCO) saw insider buying activity as Williams David Solomon III purchased 18,999 shares on June 24, 2026. This transaction wasn't part of a pre-planned trading program and reflects a direct acquisition of shares.
Insider Buying and Selling at AdaptHealth Corp.
On June 24, 2026, Williams David Solomon III bought 18,999 shares of AdaptHealth Corp. The transaction wasn't pre-arranged under a Rule 10b5-1 plan. Other recent insider activities include Susan Weaver purchasing 18,999 shares on the same day. Additionally, Chief Operating Officer Daniel Edward McFadden acquired 20,134 shares on May 27, 2026. Meanwhile, Chief Commercial Officer Russell Schuster III sold 11,275 shares on June 1, 2026, under a pre-planned trading program.
Other Institutional Activity in AdaptHealth Corp.
Several institutional investors have also been active in AdaptHealth. OEP Capital Advisors, L.P. increased its holdings by 2,494,518 shares, bringing its total to 16,312,698 shares valued at approximately $194.1 million, representing an 18.1% increase. BlackRock, Inc. added 247,939 shares, ending with 15,939,953 shares valued at about $189.7 million, marking a 1.6% increase. Reinhart Partners, LLC. grew its stake by 1,981,198 shares to 10,081,983 shares, worth around $120 million, a 24.5% increase. Deerfield Management Company, L.P. and SkyKnight Capital, L.P. maintained their positions without changes.
AdaptHealth Corp. Stock Up 77.4%
As of Saturday, shares of AdaptHealth Corp. traded near $10.18. The company has a market capitalization of approximately $1.4 billion and a forward P/E ratio of 8.75, indicating expectations of future earnings growth. The stock's beta is 1.463, suggesting it is more volatile than the market. Over the past year, AdaptHealth's shares have ranged from a low of $8.51 to a high of $13.43. The stock's 50-day moving average is $10.99, while its 200-day moving average is $10.21.
$AHCO stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
AdaptHealth reported revenues of approximately $3.29 billion, reflecting a growth of 5.4%. However, the company is currently not profitable, with a net margin of -2.42% and a return on equity of -4.85%. The next earnings report is expected on August 4, 2026.
Analysts Set New Price Targets
On May 11, 2026, RBC Capital maintained its 'buy' rating for AdaptHealth with a price target of $15. Canaccord Genuity and UBS also maintained 'buy' ratings, with price targets of $16 and $14, respectively, both on May 6, 2026. The consensus among analysts is a 'buy' rating, with a mean target price of $14 based on eight analyst opinions.
About AdaptHealth Corp.
AdaptHealth Corp., headquartered in Conshohocken, Pennsylvania, is a healthcare company providing home medical equipment and related services. It operates through various segments, including Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. The company offers a range of medical devices and services, such as sleep therapy and diabetes management equipment. AdaptHealth serves Medicare, Medicaid, and commercial insurance beneficiaries across the United States.
Bottom Line
Insider buying by Williams David Solomon III suggests confidence in AdaptHealth Corp.'s prospects. The company, with a market cap of about $1.4 billion, operates in the healthcare sector, specializing in home medical equipment. While the company isn't currently profitable, its revenue growth and analyst support indicate potential for future performance. As always, 13F filings and insider transactions are backward-looking and may not reflect the current state of holdings.
Get AdaptHealth Corp. alerts
New 13F filings, insider trades, and analyst moves on $AHCO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.